Skip to the main content

ADMET and DMPK, Vol. 14 , 2026.

Review article

https://doi.org/https://doi.org/10.5599/admet.3281

Leveraging network pharmacology in the treatment of asthma

Sarthi Ahuja ; School of Pharmacy, National Forensic Science University, Gandhinagar, Gujarat, 382 007, India
Richard Cherehani Kashindye ; School of Pharmacy, National Forensic Science University, Gandhinagar, Gujarat, 382 007, India
Divya Yadav ; SGT College of Pharmacy, SGT University, Gurugram, 122 505, India
Priyanka Chaudhary ; School of Pharmacy, National Forensic Science University, Gandhinagar, Gujarat, 382 007, India
Rakesh Yadav orcid id orcid.org/0000-0002-8932-5076 ; School of Pharmacy, National Forensic Science University, Gandhinagar, Gujarat, 382 007, India *

* Corresponding author.

Full text: english pdf 1.085 Kb

downloads: 0

cite

Abstract

Background and purpose: Asthma, a chronic airway inflammatory disorder driven by multifaceted genetic, cellular and molecular interactions, remains inadequately managed by single-target therapies due to incomplete disease control and adverse effects; this review aimed to explore network pharmacology's role in elucidating multi-target mechanisms of phytotherapeutic agents for asthma, with a focus on integrating ADMET/DMPK profiling to predict clinical translatability and safety. Experimental approach: We employed network pharmacology methodologies including target prediction (e.g. via PharmMapper, PubChem), protein-protein interaction network construction (STRING, Cytoscape), pathway enrichment analysis (KEGG, Reactome), molecular docking (AutoDock) and ADMET/DMPK modelling (SwissADME, pkCSM) to dissect multi-component herbal formulations, complemented by literature-mined experimental validations. Key results: Analyses identified key asthma-related targets (e.g. IL-17, TNF) and pathways (JAK-STAT, PI3K-AKT), revealing quercetin and kaempferol's multi-target efficacy in reducing airway inflammation and immune dysregulation; favourable ADMET profiles (high oral bioavailability, low toxicity) and DMPK parameters (metabolic stability via CYP inhibition) supported their therapeutic potential in herbal combinations. Conclusion: Network pharmacology, enhanced by ADMET/DMPK integration, advances a holistic under­standing of herbal asthma treatments, promoting safe, multi-target drug development. Limitations include data gaps in multi-omics validation and herbal standardization, with future directions leveraging AI-driven predictions for personalized pharmacotherapy.

Keywords

Molecular dynamics simulation; molecular docking; herbal medicine; systems pharmacology; multi-target therapy

Hrčak ID:

350191

URI

https://hrcak.srce.hr/350191

Publication date:

7.5.2026.

Visits: 0 *